Takeda Pharmaceutical Co. Ltd. has signed two licensing agreements with major Indian vaccines manufacturer Biological E Ltd. (BE) for the transfer of technology the partners say will enable the development, manufacture and delivery of affordable combination vaccines to lower income countries.
Takeda will allow BE to access its technology for the bulk production of measles and acellular pertussis vaccines, and will...








